サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676126

哺乳類細胞発酵技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Mammalian Cell Fermentation Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
哺乳類細胞発酵技術の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

哺乳類細胞発酵技術の世界市場規模は、2024年の524億2,000万米ドルから2033年には1,165億3,000万米ドルに成長し、2026年から2033年の予測期間中に9.28％の堅調な年間平均成長率（CAGR）を示すと予測されます。

哺乳類細胞発酵技術市場は、バイオ医薬品と生物製剤の需要が増加し続けていることから、大きな成長が見込まれています。哺乳類細胞発酵は、治療用タンパク質、モノクローナル抗体、ワクチンの生産において重要なプロセスであり、バイオ医薬品産業にとって不可欠なものとなっています。慢性疾患の有病率の増加と個別化医療への関心の高まりが、哺乳類細胞発酵技術への投資を促進し、市場拡大をさらに後押ししています。

技術の進歩は、哺乳類細胞発酵技術市場の将来を形作る上で重要な役割を果たしています。バイオリアクター設計、細胞培養培地、プロセス最適化における革新は、哺乳類細胞発酵プロセスの効率性と拡張性を高めています。さらに、自動化とデータ分析の統合により、発酵プロセスのモニタリングと制御が改善され、より高い収率と生産時間の短縮が可能となっています。メーカーが革新的な新ソリューションを開発し続けているため、哺乳類細胞発酵技術市場は、様々なバイオ医薬品用途で採用が拡大するとみられます。

さらに、規制遵守と品質保証の重視の高まりが、哺乳類細胞発酵技術市場の成長軌道に影響を与えています。規制当局がバイオ医薬品製造についてより厳格なガイドラインを実施するにつれて、これらの基準を満たす発酵技術に対する需要が高まると予想されます。この動向は、コンプライアンスを確保し、製品の品質を高める統合ソリューションを開発するために、技術プロバイダーとバイオ医薬品企業との協力を促進しています。市場が進化を続ける中、技術、規制遵守、品質管理の統合が成功の重要な促進要因となるでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 哺乳類細胞発酵技術産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 哺乳類細胞発酵技術の世界市場分析：タイプ別

  • 概要：タイプ別
  • 実績・予測データ分析：タイプ別
  • チャイニーズハムスター卵巣（CHO）細胞発酵
  • ヒト胚性腎臓（HEK）細胞発酵
  • ベビーハムスター腎臓（BHK）細胞発酵
  • マウス骨髄腫細胞発酵
  • その他

第6章 哺乳類細胞発酵技術の世界市場分析：用途別

  • 概要：用途別
  • 実績・予測データ分析：用途別
  • モノクローナル抗体
  • 組み換えタンパク質
  • ワクチン
  • ホルモン
  • 酵素
  • その他

第7章 哺乳類細胞発酵技術の世界市場分析：最終用途別

  • 概要：最終用途別
  • 実績・予測データ分析：最終用途別
  • バイオ医薬品企業
  • CMOおよびCDMO
  • 学術・研究機関

第8章 哺乳類細胞発酵技術の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 哺乳類細胞発酵技術企業の競合情勢

  • 哺乳類細胞発酵技術市場の競合
  • パートナーシップ／共同研究／協定
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher
  • Lonza
  • F. Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen
  • Gilead Sciences
  • Moderna Inc.
  • Regeneron Pharmaceuticals
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Chinese Hamster Ovary (CHO) Cell Fermentation Market Sales By Geography (USD MN)
  • Human Embryonic Kidney (HEK) Cell Fermentation Market Sales By Geography (USD MN)
  • Baby Hamster Kidney (BHK) Cell Fermentation Market Sales By Geography (USD MN)
  • Murine Myeloma Cell Fermentation Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Hormones Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • CMOs & CDMOs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Mammalian Cell Fermentation Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Mammalian Cell Fermentation Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Mammalian Cell Fermentation Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Chinese Hamster Ovary (CHO) Cell Fermentation Market Sales By Geography (USD MN)
  • Human Embryonic Kidney (HEK) Cell Fermentation Market Sales By Geography (USD MN)
  • Baby Hamster Kidney (BHK) Cell Fermentation Market Sales By Geography (USD MN)
  • Murine Myeloma Cell Fermentation Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Monoclonal Antibodies Market Sales By Geography (USD MN)
  • Recombinant Proteins Market Sales By Geography (USD MN)
  • Vaccines Market Sales By Geography (USD MN)
  • Hormones Market Sales By Geography (USD MN)
  • Enzymes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • CMOs & CDMOs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR112112214

Global Mammalian Cell Fermentation Technology Market size is anticipated to grow from USD 52.42 Billion in 2024 to USD 116.53 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.28% during the forecast period of 2026 to 2033.

The Mammalian Cell Fermentation Technology Market is poised for significant growth as the demand for biopharmaceuticals and biologics continues to rise. Mammalian cell fermentation is a critical process in the production of therapeutic proteins, monoclonal antibodies, and vaccines, making it essential for the biopharmaceutical industry. The increasing prevalence of chronic diseases and the growing focus on personalized medicine are driving investments in mammalian cell fermentation technologies, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the mammalian cell fermentation technology market. Innovations in bioreactor design, cell culture media, and process optimization are enhancing the efficiency and scalability of mammalian cell fermentation processes. Additionally, the integration of automation and data analytics is improving the monitoring and control of fermentation processes, enabling higher yields and reduced production times. As manufacturers continue to innovate and develop new solutions, the mammalian cell fermentation technology market is likely to see increased adoption across various biopharmaceutical applications.

Moreover, the growing emphasis on regulatory compliance and quality assurance is influencing the mammalian cell fermentation technology market's growth trajectory. As regulatory agencies implement stricter guidelines for biopharmaceutical production, the demand for fermentation technologies that meet these standards is expected to rise. This trend is driving collaboration between technology providers and biopharmaceutical companies to develop integrated solutions that ensure compliance and enhance product quality. As the market continues to evolve, the integration of technology, regulatory compliance, and quality management will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Chinese Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

By Application

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Hormones
  • Enzymes
  • Others

By End-Use

  • Biopharmaceutical Companies
  • CMOs & CDMOs
  • Academic & Research Institutes
  • COMPANIES PROFILED
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher
  • Lonza
  • F. Hoffmann-La Roche Ltd
  • Sartorius AG
  • AstraZeneca
  • Bristol-Myers Squibb
  • Amgen
  • Gilead Sciences
  • Moderna Inc.
  • Regeneron Pharmaceuticals.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Chinese Hamster Ovary (CHO) Cell Fermentation Historic and Forecast Sales By Regions
  • 5.4. Human Embryonic Kidney (HEK) Cell Fermentation Historic and Forecast Sales By Regions
  • 5.5. Baby Hamster Kidney (BHK) Cell Fermentation Historic and Forecast Sales By Regions
  • 5.6. Murine Myeloma Cell Fermentation Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Monoclonal Antibodies Historic and Forecast Sales By Regions
  • 6.4. Recombinant Proteins Historic and Forecast Sales By Regions
  • 6.5. Vaccines Historic and Forecast Sales By Regions
  • 6.6. Hormones Historic and Forecast Sales By Regions
  • 6.7. Enzymes Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.4. CMOs & CDMOs Historic and Forecast Sales By Regions
  • 7.5. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MAMMALIAN CELL FERMENTATION TECHNOLOGY COMPANIES

  • 9.1. Mammalian Cell Fermentation Technology Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF MAMMALIAN CELL FERMENTATION TECHNOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Merck KGaA
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Danaher
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Lonza
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. F. Hoffmann-La Roche Ltd
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Sartorius AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. AstraZeneca
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bristol-Myers Squibb
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Amgen
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Gilead Sciences
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Moderna Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Regeneron Pharmaceuticals
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies